2015
DOI: 10.1097/moh.0000000000000100
|View full text |Cite
|
Sign up to set email alerts
|

Neutrophilic dermatosis

Abstract: Recent insights into neutrophilic dermatosis' pathophysiology have encouraged the use of targeted biological therapies for their treatment. Although systemic glucocorticoids remain the mainstay of treatment for Sweet's syndrome and pyoderma gangrenosum, anti-TNF-α is becoming the preferred treatment when pyoderma gangrenosum is accompanied by inflammatory bowel disease or rheumatoid arthritis. Interleukin-1 receptor inhibitor anakinra is a promising therapeutic alternative for refractory Sweet's syndrome.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(10 citation statements)
references
References 56 publications
0
9
0
1
Order By: Relevance
“…IL-8, which is also known as “neutrophil chemotactic factor”, plays a central role in neutrophil functions by inducing both chemotaxis and phagocytosis [ 28 ]. The mucocutaneous lesions (e.g., Pathergy reaction, pustular folliculitis) which are the hallmarks of BD, characteristically demonstrate significant neutrophilic infiltrates [ 29 31 ]. Additionally, IL-8 has previously shown to be increased in BD patients [ 32 , 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…IL-8, which is also known as “neutrophil chemotactic factor”, plays a central role in neutrophil functions by inducing both chemotaxis and phagocytosis [ 28 ]. The mucocutaneous lesions (e.g., Pathergy reaction, pustular folliculitis) which are the hallmarks of BD, characteristically demonstrate significant neutrophilic infiltrates [ 29 31 ]. Additionally, IL-8 has previously shown to be increased in BD patients [ 32 , 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…Metronidazole has been effective in patients whose dermatosis is related to inflammatory bowel disease [ 4 ]. Tumor necrosis factor (TNF) antagonists such as etanercept, infliximab, and thalidomide have been shown to be effective [ 4 , 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…Often these diseases are associated with other autoimmune or inflammatory processes, such as inflammatory bowel disease [133, 134]. A variety of neutrophil functional defects, in chemotaxis, phagocytosis and other functions have been linked to various neutrophilic dermatoses, but as yet there is little molecular understanding of these processes.…”
Section: Roles For Neutrophils In Non-classical Autoinflammatory-lmentioning
confidence: 99%